Is there an association between variants in candidate insulin pathway genes IGF-I, IGFBP-3, INSR, and IRS2 and risk of colorectal cancer in the Iranian Population?

Asian Pacific Journal of Cancer Prevention

Volumn 14, Issue 9, 2013, Pages 5011-5016

  Karimi, Khatoon ^a   Mahmoudi, Touraj ^a   Karimi, Negar ^a   Dolatmoradi, Hesamodin ^a   Arkani, Maral ^a   Farahani, Hamid ^b   Vahedi, Mohsen ^c   Parsimehr, Elham ^a   Dabiri, Reza ^d   Nobakht, Hossein ^d   Asadi, Asadollah ^e   Zali, Mohammad Reza ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b QOM UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d SEMNAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e UNIVERSITY OF MOHAGHEGH ARDABILI   (Iran)

Author keywords

Colorectal cancer; Insulin pathway genes; PCR RFLP; Polymorphism

Indexed keywords

IGF1 PROTEIN, HUMAN; IGFBP3 PROTEIN, HUMAN; INSR PROTEIN, HUMAN; INSULIN RECEPTOR; INSULIN RECEPTOR SUBSTRATE; IRS2 PROTEIN, HUMAN; LEUKOCYTE ANTIGEN; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ADOLESCENT; ADULT; AGED; BODY MASS; CARCINOMA; CASE CONTROL STUDY; COLORECTAL NEOPLASMS; DIABETES MELLITUS, TYPE 2; EPIDEMIOLOGY; FEMALE; GENE FREQUENCY; GENETICS; GENOTYPE; HUMAN; IRAN; MALE; MIDDLE AGED; OBESITY; PROTECTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD; BODY MASS INDEX; CARCINOMA; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; DIABETES MELLITUS, TYPE 2; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; INSULIN RECEPTOR SUBSTRATE PROTEINS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; IRAN; MALE; MIDDLE AGED; OBESITY; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTECTIVE FACTORS; RECEPTOR, INSULIN; RISK FACTORS; YOUNG ADULT;

EID: 84887586614     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2013.14.9.5011     Document Type: Article

References (44)

1. Baroudi Ouederni T, Sanchez-Corona J, Flores Martinez SE, et al (2009). The G1057D polymorphism of IRS2 gene is not associated with type 2 diabetes and obese patients among ethnic groups in Tunisian population. Clin Biochem, 42, 1169-73.
2. Biddinger SB, Kahn CR (2006). From mice to men: insights into the insulin resistance syndromes. Annu Rev Physiol, 68, 123-58.
3. Bodhini D, Radha V, Deepa R, et al (2007). The G1057D polymorphism of IRS-2 gene and its relationship with obesity in conferring susceptibility to type 2 diabetes in Asian Indians. Int J Obes (Lond), 31, 97-102.
4. Chapelle A (2004). Genetic predisposition to colorectal cancer. Nat Rev Cancer, 4, 769-80.
5. Chung YW, Han DS, Park KH, et al (2008). Insulin therapy and colorectal adenoma risk among patients with Type 2 diabetes mellitus: a case-control study in Korea. Dis Colon Rectum, 51, 593-7.
6. Conne B, Stutz A, Vassalli JD (2000). The 3' untranslated region of messenger RNA: a molecular "hotspot" for pathology? Nat Med, 6, 637-41.
7. Davies M, Gupta S, Goldspink G, et al (2006). The insulin-like growth factor system and colorectal cancer: clinical and experimental evidence. Int J Colorectal Dis, 21, 201-8.
8. Deming SL, Ren Z, Cai Q, et al (2008). IGF-1 and IGF-2 genetic variation and breast cancer risk in Chinese Women: Results from the Shanghai Breast Cancer Study. Cancer Epidemiol Biomarkers Prev, 17, 255-7.
9. Deming SL, Ren Z, Wen W, et al (2007). Genetic variation in IGF1, IGF-1R, IGFALS, and IGFBP3 in breast cancer survival among Chinese women: a report from the Shanghai Breast Cancer Study. Breast Cancer Res Treat, 104, 309-19.
10. Feigelson HS, Teras LR, Diver WR, et al (2008). Genetic variation in candidate obesity genes ADRB2, ADRB3,GHRL, HSD11B1, IRS1, IRS2, and SHC1 and risk for breast cancer in the Cancer Prevention Study II. Breast Cancer Res, 10, 57.
11. Feik E, Baierl A, Hieger B, et al (2010). Association of IGF1 and IGFBP3 polymorphisms with colorectal polyps and colorectal cancer risk. Cancer Causes Control, 21, 91-7.
12. Ferlay J, Shin HR, Bray F, et al (2010). Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer, 127, 2893-917.
13. Flores-Martínez SE, Islas-Andrade S, Machorro-Lazo MV, et al (2004). DNA polymorphism analysis of candidate genes for type 2 diabetes mellitus in a Mexican ethnic group. Ann Genet, 47, 339-48.
14. Giovannucci E (1995). Insulin and colon cancer. Cancer Causes Control, 6, 164-79.
15. Giovannucci E (2001). Insulin, insulin-like growth factors and colon cancer: a review of the evidence. J Nutr, 131, 3109-20.
16. Gunter MJ, Hayes RB, Chatterjee N, et al (2007). Insulin resistance-related genes and advanced left-sided colorectal adenoma. Cancer Epidemiol Biomarkers Prev, 16, 703-8.
17. Ho GY, Melman A, Liu SM, et al (2003). Polymorphism of the insulin gene is associated with increased prostate cancer risk. Br J Cancer, 88, 263-9.
18. Kaaks R, Lukanova A (2001). Energy balance and cancer: the role of insulin and insulin-like growth factor-I. Proc Nutr Soc, 60, 91-106.
19. Khandwala HM, McCutcheon IE, Flyvbjerg A, et al (2000). The effects of insulin-like growth factors on tumorigenesis and neoplastic growth. Endocr Rev, 21, 215-44.
20. Kohanski RA (1993). Insulin receptor autophosphorylation I. Autophosphorylation kinetics of the native receptor and its cytoplasmic kinase domain. Biochemistry, 32, 5766-72.
21. Larsson SC, Orsini N, Wolk A (2005). Diabetes mellitus and risk of colorectal cancer: a meta-analysis. J Natl Cancer Inst, 97, 1679-87.
22. Lautier C, EI Mkadem S, Renard E, et al (2003). Complex haplotypes of IRS2 gene are associated with severe obesity and reveal heterogeneity in the effect of Gly1057Asp mutation. Hum Genet, 113, 34-43.
23. Lee DH, Kim JY, Lee MK, et al (2013). Effects of a 12-week home-based exercise program on the level of physical activity, insulin, and cytokines in colorectal cancer survivors: a pilot study. Support Care Cancer, [Epub ahead of print].
24. Malodobra M, Pilecka A, Gworys B, et al (2011). Single nucleotide polymorphisms within functional regions of genes implicated in insulin action and association with the insulin resistant phenotype. Mol Cell Biochem, 349, 187-93.
25. Moschos SJ, Mantzoros CS (2002). The role of the IGF system in cancer: from basic to clinical studies and clinical applications. Oncol, 63, 317-32.
26. Nagel JM, Göke B (2006). Colorectal carcinoma screening in patients with type 2 diabetes mellitus. Z Gastroenterol, 44, 1153-65.
27. Neuhausen SL, Slattery ML, Garner CP, et al (2005). Prostate cancer risk and IRS1, IRS2, IGF1, and INS polymorphisms: Strong association of IRS1 G972R variant and cancer risk. Prostate, 64, 168-74.
28. Patel AV, Cheng I, Canzian F, et al (2008). IGF-1, IGFBP-1, and IGFBP-3 polymorphisms predict circulating IGF levels but not breast cancer risk: findings from the Breast and Prostate Cancer Cohort Consortium (BPC3). PLoS One, 3, 2578.
29. Pechlivanis S, Pardini B, Bermejo JL, et al (2007). Insulin pathway related genes and risk of colorectal cancer: INSR promoter polymorphism shows a protective effect. Endocr Relat Cancer, 14, 733-40.
30. Pechlivanis S, Wagner K, Chang-Claude J, et al (2007). Polymorphisms in the insulin like growth factor 1 and IGF binding protein 3 genes and risk of colorectal cancer. Cancer Detect Prev, 31, 408-16.
31. Pollak MN, Schernhammer ES, Hankinson SE (2004). Insulin-like growth factors and neoplasia. Nat Rev Cancer, 4, 505-18.
32. Renehan AG, Zwahlen M, Minder C, O'Dwyer ST, et al (2004). Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis. Lancet, 363, 1346-53.
33. Sarma AV, Dunn RL, Lange LA, et al (2008). Genetic polymorphisms in CYP17, CYP3A4, CYP19A1, SRD5A2, IGF-1, and IGFBP-3 and prostate cancer risk in African-American men: the flint men's health study. Prostate, 68, 296-305.
34. Slattery ML, Murtaugh M, Caan B, et al (2005). Energy balance, insulin-related genes and risk of colon and rectal cancer. Int J Cancer, 115, 148-54.
35. Tamakoshi K, Wakai K, Kojima M, et al (2004). A prospective study of body size and colon cancer mortality in Japan: the JACC Study. Int J Obes Relat Metab Disord, 28, 551-8.
36. Vella A, Bouatia-Naji N, Heude B, et al (2008). Association analysis of the IGF1 gene with childhood growth, IGF-1 concentrations and type 1 diabetes. Diabetologia, 51, 811-5.
37. White MF (2006). Regulating insulin signaling and beta cell function through IRS proteins. Can J Physiol Pharmacol, 84, 725-37.
38. White MF (1997). The insulin signaling system and the IRS proteins. Diabetologia, 40, 2-17.
39. Wong HL, Koh WP, Probst-Hensch NM, et al (2008). Insulin-like growth factor-1 promoter polymorphisms and colorectal cancer: a functional genomics approach. Gut, 57, 1090-6.
40. Wong HL, Delellis K, Probst-Hensch N, et al (2005). A new single nucleotide polymorphism in the insulin-like growth factor I regulatory region associates with colorectal cancer risk in singapore chinese. Cancer Epidemiol Biomarkers Prev, 14, 144-51.
41. Xuefen Su, Colditz GA, Willett WC, et al (2010). Genetic variation and circulating levels of IGF-I and IGFBP-3 in relation to risk of proliferative benign breast disease. Int J Cancer, 126, 180-90.
42. Yam D, Fink A, Mashiah A, et al (1996). Hyperinsulinemia in colon, stomach and breast cancer patients. Cancer Lett, 104, 129-32.
43. Yang YX, Hennessy S, Lewis JD (2004). Insulin therapy and colorectal cancer risk among type 2 diabetes mellitus patients. Gastroenterol, 127, 1044-50.
44. Zhang H, Kong WJ, Shan YQ, et al (2010). Protein kinase D activation stimulates the transcription of the insulin receptor gene. Mol Cell Endocrinol, 330, 25-32.